SE435569B - Forfarande for framstellning av en medicinsk tablett med reglerad frigoring - Google Patents

Forfarande for framstellning av en medicinsk tablett med reglerad frigoring

Info

Publication number
SE435569B
SE435569B SE7611241A SE7611241A SE435569B SE 435569 B SE435569 B SE 435569B SE 7611241 A SE7611241 A SE 7611241A SE 7611241 A SE7611241 A SE 7611241A SE 435569 B SE435569 B SE 435569B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
medical table
regulated release
regulated
Prior art date
Application number
SE7611241A
Other languages
English (en)
Swedish (sv)
Other versions
SE7611241L (sv
Inventor
R W Walton A L Weiss
Lorimier A E De
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE7611241L publication Critical patent/SE7611241L/xx
Publication of SE435569B publication Critical patent/SE435569B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
SE7611241A 1975-10-10 1976-10-08 Forfarande for framstellning av en medicinsk tablett med reglerad frigoring SE435569B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62131675A 1975-10-10 1975-10-10

Publications (2)

Publication Number Publication Date
SE7611241L SE7611241L (sv) 1977-04-11
SE435569B true SE435569B (sv) 1984-10-08

Family

ID=24489671

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7611241A SE435569B (sv) 1975-10-10 1976-10-08 Forfarande for framstellning av en medicinsk tablett med reglerad frigoring

Country Status (16)

Country Link
JP (1) JPS5264420A (nl)
AU (1) AU516051B2 (nl)
BE (1) BE847095A (nl)
CA (1) CA1097220A (nl)
CH (1) CH616843A5 (nl)
DE (1) DE2645547A1 (nl)
DK (1) DK454876A (nl)
FR (1) FR2326933A1 (nl)
GB (1) GB1568837A (nl)
HU (1) HU175540B (nl)
IE (1) IE44540B1 (nl)
NL (1) NL7611148A (nl)
NO (1) NO763450L (nl)
PH (1) PH14564A (nl)
SE (1) SE435569B (nl)
ZA (1) ZA765931B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
JPS5626810A (en) * 1979-08-06 1981-03-16 Kurishiyuna Mitora Arun Antiacid delivering form controlled and treating method using said form
FR2494112B1 (nl) * 1980-11-19 1986-01-10 Laruelle Claude
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
HU190619B (en) 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3448522C2 (de) * 1983-11-11 1995-08-24 Egyt Gyogyszervegyeszeti Gyar Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
DE3420666A1 (de) 1984-06-02 1985-12-05 Mannesmann Rexroth GmbH, 8770 Lohr Niveauregeleinrichtung fuer fahrzeuge mit mindestens einem hydraulischen schwingungsdaempfer
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
JPH0667828B2 (ja) * 1985-10-09 1994-08-31 日研化学株式会社 バルプロ酸ナトリウムの持続性顆粒製剤
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
IL119627A (en) 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet

Also Published As

Publication number Publication date
IE44540B1 (en) 1981-12-30
DE2645547A1 (de) 1977-04-14
NO763450L (nl) 1977-04-13
DK454876A (da) 1977-04-11
CH616843A5 (en) 1980-04-30
GB1568837A (en) 1980-06-04
FR2326933B1 (nl) 1979-03-02
PH14564A (en) 1981-09-24
ZA765931B (en) 1977-09-28
BE847095A (fr) 1977-01-31
AU516051B2 (en) 1981-05-14
CA1097220A (en) 1981-03-10
AU1844676A (en) 1978-04-13
SE7611241L (sv) 1977-04-11
IE44540L (en) 1977-04-10
JPS5264420A (en) 1977-05-27
FR2326933A1 (fr) 1977-05-06
HU175540B (hu) 1980-08-28
NL7611148A (nl) 1977-04-13

Similar Documents

Publication Publication Date Title
SE435569B (sv) Forfarande for framstellning av en medicinsk tablett med reglerad frigoring
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
MX4502E (es) Procedimiento para preparar 9alfa-hidroxiandrostenodiona
MX4047E (es) Procedimiento para preparar aralquilimidazoles
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
MX3638E (es) Procedimiento para preparar metilpirazolilamidas
SE403380B (sv) Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner
SE429285B (sv) Forfarande for framstellning av en fettprodukt med forbettrade smorliknande egenskaper
NO146044C (no) Fremgangsmaate for fremstilling av et farmasoeytisk insulin-preparat for rektal bruk
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
MX3832E (es) Procedimiento para preparar pirazolinonas
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
RO69885A (ro) Procedeu de preparare a l-piroglutamil-l-prolinamidei
SE420890B (sv) Forfarande for framstellning av flernyanserade komprimerade tablettdoseringsformer
MX4603E (es) Procedimiento para prepara derivados de vincamina
SE7801664L (sv) Forfarande for framstellning av en komposition med anestetisk effekt
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
IT1068946B (it) Procedimento per prepararae triemtilidrochinone
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE414927B (sv) Forfarande for framstellning av 1-metyl-2-(fenyloximetyl)-5-nitroimidazoler